The U.S. surgeon general on Thursday called for action to reduce the use of e-cigarettes among young people. » Read More
By: Dan Mangan
The American Academy of Actuaries said more insurers could bolt the market, and fewer people could end up being insured. » Read More
By: Dan Mangan
President-elect Donald Trump made his promise, which echoes past criticisms on drug pricing, in an interview for Time magazine's Person of the Year issue. » Read More
Big employers will see health costs grow in line with trends, but there's a shift in what's driving spending, PwC's Health Research Institute says.
Emergent BioSolutions moved closer to FDA approval for a large-scale facility for making BioThrax, a vaccine for protection against anthrax.
The jury remains out on whether the slowdown in health spending is due to Obamacare or the overall economy.
The zika virus could already have a foothold in the southern United States, and public health officials are unprepared for it.
Google wants to make it easier for users to find answers to their symptom-related questions with medical information from doctors.
The rapid increase in Zika virus infections in Puerto Rico could put thousands of pregnant women at risk for potential infection.
Shares of Envision Healthcare Holdings dropped more than 5 percent following news of its merger with AmSurg.
Given high health costs in retirement, some workers are better off saving via workplace health savings accounts rather than 401(k) plans.
Big investors are betting that business will boom for this health insurance start-up if Obamacare becomes profitable. And that's a big if.
The federal government is offering state insurance regulators $22 million to use toward making sure insurers follow Obamacare rules.
Double-digit proposed price increases are the norm for key Obamacare plans in 14 major U.S. cities.
All "very hot" drinks are probably carcinogenic, the World Health Organization's cancer agency will say as it downgrades warning on coffee.
The biopharmaceutical company authorized a repurchase of up to an additional $3 billion to its shareholders.
Some common weight-loss drugs seem to work better than others, according to a new study in a respected medical journal.
A new device that drains a portion of a person's stomach contents after every meal, has just won approval from the U.S. Food and Drug Administration.
The major doctors group said it wants Congress to fund research into the problem.
Get the best of CNBC in your inbox